Data for ST001460
Metabolite structure | All data | F1 | F2 | F3 |
---|---|---|---|---|
Ace-2_1 | 9.20 | - | - | |
aGlc_1 | 99.51 | 107.77 | 96.44 | |
Ala-3_1 | 25.93 | 12.88 | 18.23 | |
Ala-3_2 | 23.75 | 9.66 | 15.29 | |
Asp-3b_1 | 16.31 | 3.76 | 10.26 | |
Asp-3b_2 | 11.48 | 7.90 | 7.67 | |
AXP-1^_1 | 20.43 | 6.73 | 10.65 | |
AXP-1^_2 | 2.83 | - | - | |
AXP-2_1 | 3.99 | 2.41 | 2.56 | |
AXP-8_1 | 1.93 | 0.73 | 2.84 | |
bGlc_1 | 50.66 | 46.70 | 41.91 | |
bGlc_2 | 40.26 | 16.28 | 37.11 | |
CXP-6_1 | 1.74 | 1.48 | 1.20 | |
CXP-6_2 | - | 3.56 | - | |
DSS_1 | 3.85 | 3.79 | 3.51 | |
Gln-3_1 | 35.35 | 8.50 | 17.27 | |
Gln-3_2 | - | 1.74 | 6.84 | |
Gln-4_1 | 5.11 | 5.84 | 2.62 | |
Gln-4_2 | 3.12 | 1.27 | 3.45 | |
Gln-4_3 | 4.23 | 0.65 | 2.50 | |
Gln-4_4 | - | - | 10.36 | |
Glu-3-a_1 | 49.32 | 9.66 | 24.04 | |
Glu-3-a_2 | 15.07 | 4.59 | 2.86 | |
Glu-3-a_3 | 7.68 | 11.99 | 14.58 | |
Glu-3-a_4 | 5.84 | - | 8.83 | |
Glu-3-a_5 | 6.89 | - | - | |
Glu-3-b_1 | 70.12 | 48.59 | 51.97 | |
Glu-3-b_2 | - | - | 13.63 | |
Glu-4_1 | 37.89 | 14.67 | 22.27 | |
Glu-4_2 | - | 1.18 | 3.80 | |
Glu-4_3 | - | 1.63 | - | |
Gly_1 | 13.07 | 9.05 | 10.55 | |
Glycogen_1 | 10.72 | 2.63 | 11.53 | |
Glycogen_2 | - | 0.47 | - | |
GSH+GSSG-3_1 | 23.56 | 1.41 | 8.07 | |
GSH+GSSG-4_1 | 4.03 | 0.95 | 1.54 | |
GSH+GSSG-4_2 | 2.07 | 1.92 | 2.19 | |
GSH+GSSG-4_3 | 0.97 | 0.49 | 1.71 | |
GSH+GSSG-4_4 | 0.67 | 0.33 | 0.26 | |
GSH+GSSG-4_5 | - | 0.07 | 0.24 | |
Lac-2_1 | 52.07 | 41.81 | 28.48 | |
Lac-2_2 | 34.16 | 16.20 | 20.59 | |
Lac-2_3 | 9.15 | - | 34.01 | |
Lac-3_1 | 111.46 | 68.86 | 72.94 | |
Lac-3_2 | 83.51 | 39.79 | 50.30 | |
m-Ins-2?_1 | 8.97 | - | 4.89 | |
NAD+-A1^_1 | 2.55 | 1.38 | 1.67 | |
NAD+-A1^_2 | 1.07 | 0.26 | 0.16 | |
NAD+-N1^_1 | 4.88 | 1.87 | 2.19 | |
NAD+-N1^_2 | 2.28 | 3.19 | 0.83 | |
Nicotin-2_1 | 1.49 | 3.32 | 1.29 | |
Nicotin-6_1 | 2.36 | 1.03 | 1.32 | |
P-Cho A_1 | 6.26 | 4.56 | 4.57 | |
pyruvate-3_1 | 0.93 | - | 1.32 | |
Succinate-2,3_1 | 2.11 | 1.19 | 2.27 | |
UXP-1^_1 | 18.78 | 4.48 | 4.06 |
Factors:
F1 | Treatment Protocol:allogenic |
F2 | Treatment Protocol:naive |
F3 | Treatment Protocol:syngenic |